Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries | Published in Journal of Health Economics and Outcomes Research

Loading [Contrib]/a11y/accessibility-menu.js

Metrics
Cost-Minimization Analysis for Subcutaneous Daratumumab in the Treatment of Newly Diagnosed Multiple Myeloma in Three Gulf Countries

Anas Hamad, Shereen Elazzazy, Ruba Y. Taha, Hani Osman, Sana Alblooshi, Islam Elkonaissi, Mustaqeem A. Siddiqui, Khalil Al-Farsi, Mohammed Al Lamki, Sali Emara, Gihan H. Elsisi,

cost-minimization analysissubcutaneous daratumumabnewly diagnosed multiple myelomaGulf countriesQatarOmanUnited Arab Emirates

• https://doi.org/10.36469/001c.120288

Pageviews and PDF downloads

Pageviews Downloads

427 all time

Last 7 days Last 30 days Last 90 days All time

Top Countries
IN	68
US	64
AE	40
QA	30
GB	29
EG	28
CA	20
SG	16
ID	9
AU	8